For research use only. Not for therapeutic Use.
Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody[1].
| Catalog Number | I041592 |
| CAS Number | 1792982-56-9 |
| Purity | ≥95% |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 30, No. 4, 2016. |
